TP53 and cancer: Zinc metallochaperones (ZMCs) were identified through a screen of the National Cancer Institute (NCI) database for substances that preferentially inhibited growth of human cancer cell lines expressing the hotspot TP53 mutations at codons 175, 248, and 273 compared to cells expressing wild-type p53 [33].